文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

使用 DWI 和高 T1 加权 DSC-MRI 预测高级别胶质瘤的 IDH 突变状态。

Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.

机构信息

Gazi University, School of Medicine, Department of Radiology, Ankara, Turkey.

Gazi University, School of Medicine, Department of Radiology, Ankara, Turkey.

出版信息

Acad Radiol. 2022 Mar;29 Suppl 3:S52-S62. doi: 10.1016/j.acra.2021.02.002. Epub 2021 Mar 6.


DOI:10.1016/j.acra.2021.02.002
PMID:33685792
Abstract

RATIONALE AND OBJECTIVES: We aimed to evaluate the diagnostic performance of diffusion-weighted imaging (DWI) and dynamic susceptibility contrast-enhanced (DSC) magnetic resonance imaging (MRI) parameters in the noninvasive prediction of the isocitrate dehydrogenase (IDH) mutation status in high-grade gliomas (HGGs). MATERIALS AND METHODS: A total of 58 patients with histopathologically proved HGGs were included in this retrospective study. All patients underwent multiparametric MRI on 3-T, including DSC-MRI and DWI before surgery. The mean apparent diffusion coefficient (ADC), relative maximum cerebral blood volume (rCBV), and percentage signal recovery (PSR) of the tumor core were measured and compared depending on the IDH mutation status and tumor grade. The Mann-Whitney U test was used to detect statistically significant differences in parameters between IDH-mutant-type (IDH-m-type) and IDH-wild-type (IDH-w-type) HGGs. Receiver operating characteristic curve (ROC) analysis was performed to evaluate the diagnostic performance. RESULTS: The rCBV was significantly higher, and the PSR value was significantly lower in IDH-w-type tumors than in the IDH-m group (p = 0.002 and <0.001, respectively).The ADC value in IDH-w-type tumors was significantly lower compared with the one in IDH-m types (p = 0.023), but remarkable overlaps were found between the groups. The PSR showed the best diagnostic performance with an AUC of 0.938 and with an accuracy rate of 0.87 at the optimal cutoff value of 86.85. The combination of the PSR and the rCBV for the identification of the IDH mutation status increased the discrimination ability at the AUC level of 0.955. In terms of each tumor grade, the PSR and rCBV showed significant differences between the IDH-m and IDH-w groups (p ≤0.001). CONCLUSION: The rCBV and PSR from DSC-MRI may be feasible noninvasive imaging parameters for predicting the IDH mutation status in HGGs. The standardization of the imaging protocol is indispensable to the utility of DSC perfusion MRI in wider clinical usage.

摘要

背景与目的:本研究旨在评估扩散加权成像(DWI)和动态对比增强磁共振成像(DSC-MRI)参数在高级别胶质瘤(HGG)患者无创预测异柠檬酸脱氢酶(IDH)突变状态中的诊断性能。

材料与方法:回顾性分析 58 例经组织病理学证实的 HGG 患者的临床资料,所有患者均于术前在 3.0T 磁共振仪上行 DSC-MRI 和 DWI 检查。测量肿瘤实质核心的平均表观扩散系数(ADC)、相对最大脑血容量(rCBV)和信号恢复百分比(PSR),并根据 IDH 突变状态和肿瘤分级进行比较。采用 Mann-Whitney U 检验比较 IDH 突变型(IDH-m 型)和 IDH 野生型(IDH-w 型)HGG 之间参数的统计学差异。采用受试者工作特征曲线(ROC)分析评价诊断效能。

结果:与 IDH-m 型肿瘤相比,IDH-w 型肿瘤的 rCBV 明显升高,PSR 值明显降低(p=0.002 和 <0.001)。与 IDH-m 型肿瘤相比,IDH-w 型肿瘤的 ADC 值明显降低(p=0.023),但两组之间存在显著重叠。PSR 的 AUC 为 0.938,最佳截断值为 86.85%时,诊断准确率为 87%,具有最佳的诊断效能。PSR 与 rCBV 联合鉴别 IDH 突变状态可提高 AUC 水平的鉴别能力(0.955)。在每个肿瘤分级中,IDH-m 型和 IDH-w 型肿瘤之间的 PSR 和 rCBV 均有显著差异(p≤0.001)。

结论:DSC-MRI 的 rCBV 和 PSR 可能是预测 HGG 中 IDH 突变状态的无创性影像学参数。为了在更广泛的临床应用中推广 DSC 灌注 MRI,需要对成像方案进行标准化。

相似文献

[1]
Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.

Acad Radiol. 2022-3

[2]
Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.

Eur Radiol. 2019-12-11

[3]
Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.

Acta Radiol. 2021-12

[4]
Noninvasive Assessment of Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging.

AJNR Am J Neuroradiol. 2017-6

[5]
Noninvasively evaluating the grade and IDH mutation status of gliomas by using mono-exponential, bi-exponential diffusion-weighted imaging and three-dimensional pseudo-continuous arterial spin labeling.

Eur J Radiol. 2023-3

[6]
Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.

Eur Radiol. 2019-8-24

[7]
Can Dynamic Susceptibility Contrast Perfusion Imaging be Utilized to Detect Isocitrate Dehydrogenase Gene Mutation in Gliomas?

Turk Neurosurg. 2022

[8]
Static F-FET PET and DSC-PWI based on hybrid PET/MR for the prediction of gliomas defined by IDH and 1p/19q status.

Eur Radiol. 2021-6

[9]
Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.

Eur Radiol. 2023-10

[10]
Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.

J Neurooncol. 2017-8

引用本文的文献

[1]
Advanced MRI, Radiomics and Radiogenomics in Unravelling Incidental Glioma Grading and Genetic Status: Where Are We?

Medicina (Kaunas). 2025-8-12

[2]
Continuous-time random walk and fractional order calculus models histogram analysis of glioma biomarkers, including , , , and , on differentiation.

Quant Imaging Med Surg. 2025-7-1

[3]
The Value of Cerebral Blood Volume Derived from Dynamic Susceptibility Contrast Perfusion MRI in Predicting IDH Mutation Status of Brain Gliomas-A Systematic Review and Meta-Analysis.

Diagnostics (Basel). 2025-4-1

[4]
Magnetic resonance diffusion-derived vessel density (DDVD) as a valuable tissue perfusion biomarker for isocitrate dehydrogenase genotyping in diffuse gliomas.

BMC Med Imaging. 2025-3-6

[5]
Preoperative prediction of IDH genotypes and prognosis in adult-type diffuse gliomas: intratumor heterogeneity habitat analysis using dynamic contrast-enhanced MRI and diffusion-weighted imaging.

Cancer Imaging. 2025-2-8

[6]
Completely non-invasive prediction of IDH mutation status based on preoperative native CT images.

Sci Rep. 2024-11-5

[7]
"Synthetic" DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar Imaging.

AJNR Am J Neuroradiol. 2025-2-3

[8]
Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study.

Neurooncol Adv. 2024-7-5

[9]
DSC-PWI presurgical differentiation of grade 4 astrocytoma and glioblastoma in young adults: rCBV percentile analysis across enhancing and non-enhancing regions.

Neuroradiology. 2024-8

[10]
Advancements in Image-Based Models for High-Grade Gliomas Might Be Accelerated.

Cancers (Basel). 2024-4-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索